Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Adjunct Therapy in Knee Osteoarthritis
NCT06231758Phase 3Recruiting
- Start
- Jan 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin in knee osteoarthritis (OA) (2 arms). Primary endpoint: Visual Analogue Scale at 3 months. Started Jan 2024; status: recruiting.
02
Drugs
metformin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06231758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06231758.